Knoll Capital Management as of Dec. 31, 2017
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 12 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abeona Therapeutics | 33.0 | $37M | 2.4M | 15.85 | |
| Corbus Pharmaceuticals Hldgs | 24.1 | $27M | 3.9M | 7.10 | |
| Biohaven Pharmaceutical Holding | 19.2 | $22M | 807k | 26.98 | |
| Ampio Pharmaceuticals | 9.3 | $11M | 2.6M | 4.07 | |
| Vascular Biogenics | 5.6 | $6.4M | 897k | 7.10 | |
| Krystal Biotech (KRYS) | 2.8 | $3.2M | 300k | 10.52 | |
| Anavex Life Sciences (AVXL) | 2.1 | $2.3M | 724k | 3.22 | |
| Soligenix | 1.6 | $1.8M | 870k | 2.11 | |
| Volitionrx (VNRX) | 0.9 | $1.0M | 352k | 2.94 | |
| Aldeyra Therapeutics (ALDX) | 0.7 | $844k | 124k | 6.80 | |
| Evoke Pharma | 0.6 | $622k | 275k | 2.26 | |
| Advaxis | 0.1 | $113k | 113k | 1.00 |
